The Aroon Indicator for APYX entered a downward trend on October 06, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 248 similar instances where the Aroon Indicator formed such a pattern. In 237 of the 248 cases the stock moved lower. This puts the odds of a downward move at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where APYX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where APYX's RSI Oscillator exited the oversold zone, 26 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 51 of 62 cases where APYX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.
The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on APYX as a result. In 89 of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 86%.
The Moving Average Convergence Divergence (MACD) for APYX just turned positive on October 12, 2026. Looking at past instances where APYX's MACD turned positive, the stock continued to rise in 42 of 48 cases over the following month. The odds of a continued upward trend are 88%.
Following a +12.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where APYX advanced for three days, in 198 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
APYX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 54 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.872) is normal, around the industry mean (10.930). P/E Ratio (0.000) is within average values for comparable stocks, (100.178). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.196) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 83 (best 1 - 100 worst), indicating slightly worse than average price growth. APYX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APYX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
RCG saw its Momentum Indicator move below the 0 level on September 25, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 153 similar instances where the indicator turned negative. In 139 of the 153 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for RCG turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 63 similar instances when the indicator turned negative. In 59 of the 63 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
RCG moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for RCG crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 16 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RCG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where RCG's RSI Indicator exited the oversold zone, 12 of 13 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +0.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where RCG advanced for three days, in 181 of 213 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
RCG may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 133 of 149 cases where RCG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.
APYX | ||
|---|---|---|
OUTLOOK RATING 1..100 | 73 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 54 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 99 | |
PRICE GROWTH RATING 1..100 | 83 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | 40 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| APYX | RCG | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 87% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 82% | 1 day ago 87% |
| Momentum ODDS (%) | 1 day ago 86% | 1 day ago 90% |
| MACD ODDS (%) | 1 day ago 88% | 1 day ago 90% |
| TrendWeek ODDS (%) | 1 day ago 88% | 1 day ago 88% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Advances ODDS (%) | 5 days ago 86% | 19 days ago 85% |
| Declines ODDS (%) | 1 day ago 89% | 2 days ago 85% |
| BollingerBands ODDS (%) | 1 day ago 89% | 1 day ago 83% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 89% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
APYX’s FA Score shows that 0 FA rating(s) are green while .
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
APYX’s TA Score shows that 6 TA indicator(s) are bullish.
APYX (@Medical/Nursing Services) experienced а -1.54% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -6.10%. For the same industry, the average monthly price growth was -8.07%, and the average quarterly price growth was -16.10%.
APYX is expected to report earnings on Nov 05, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FT | 7.17 | 0.07 | +0.99% |
| Franklin Universal Trust | |||
| EFAS | 22.07 | 0.11 | +0.51% |
| Global X MSCI SuperDividend EAFE ETF (EFAS) | |||
| IBTL | 19.59 | 0.02 | +0.10% |
| iShares iBonds Dec 2031 Term Treasury ETF (IBTL) | |||
| MKAM | 32.22 | -0.18 | -0.57% |
| MKAM ETF (MKAM) | |||
| DFAU | 52.51 | -0.58 | -1.09% |
| Dimensional US Core Equity Market ETF (DFAU) | |||
A.I.dvisor tells us that APYX and ITOC have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APYX and ITOC's prices will move in lockstep.
| Ticker / NAME | Correlation To APYX | 1D Price Change % | ||
|---|---|---|---|---|
| APYX | 100% | -0.39% | ||
| ITOC - APYX | 26% Poorly correlated | -4.24% | ||
| CLPT - APYX | 25% Poorly correlated | -5.91% | ||
| EMBC - APYX | 25% Poorly correlated | -2.79% | ||
| A - APYX | 25% Poorly correlated | -1.47% | ||
| NVNO - APYX | 25% Poorly correlated | -5.74% | ||
More | ||||
A.I.dvisor tells us that RCG and MSB have been poorly correlated (+12% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RCG and MSB's prices will move in lockstep.
| Ticker / NAME | Correlation To RCG | 1D Price Change % | ||
|---|---|---|---|---|
| RCG | 100% | N/A | ||
| MSB - RCG | 12% Poorly correlated | -0.89% | ||
| CACI - RCG | 11% Poorly correlated | +0.48% | ||
| APYX - RCG | 6% Poorly correlated | -0.39% | ||
| FTLF - RCG | 4% Poorly correlated | -1.53% | ||
| TPL - RCG | 3% Poorly correlated | +1.27% | ||
More | ||||